Lawrence Sher

AR101 Oral Immunotherapy for Peanut Allergy

William H. Yang, N. Rupp, G. Toit, 2018, The New England journal of medicine.

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.

E. Kerwin, E. Bleecker, D. Bernstein, 2017, The Lancet. Respiratory medicine.